{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:59:26Z","timestamp":1787165966898,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970698"],"award-info":[{"award-number":["31970698"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023YFS0109"],"award-info":[{"award-number":["2023YFS0109"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78634-6","type":"journal-article","created":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T22:40:08Z","timestamp":1731278408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Analyzing immune cell infiltrates in skeletal muscle of infantile-onset Pompe disease using bioinformatics and machine learning"],"prefix":"10.1038","volume":"14","author":[{"given":"Jingfei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"issue":"1","key":"78634_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ymgme.2019.11.005","volume":"129","author":"BL Farah","year":"2020","unstructured":"Farah, B. L., Yen, P. M. & Koeberl, D. D. Links between autophagy and disorders of glycogen metabolism - perspectives on pathogenesis and possible treatments. Mol. Genet. Metab. 129 (1), 3\u201312 (2020).","journal-title":"Mol. Genet. Metab."},{"issue":"13","key":"78634_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.21037\/atm.2019.04.13","volume":"7","author":"P Peruzzo","year":"2019","unstructured":"Peruzzo, P., Pavan, E. & Dardis, A. Molecular genetics of pompe disease: Acomprehensive overview. Ann. Transl Med. 7 (13), 278 (2019).","journal-title":"Ann. Transl Med."},{"issue":"5","key":"78634_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","volume":"8","author":"PS Kishnani","year":"2006","unstructured":"Kishnani, P. S. et al. Pompe disease diagnosis and management guideline. Genet. Med. 8 (5), 267\u2013288 (2006).","journal-title":"Genet. Med."},{"issue":"5","key":"78634_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","volume":"148","author":"PS Kishnani","year":"2006","unstructured":"Kishnani, P. S. et al. A retrospective, multinational, multicenter study on the natural history of infantile-onset pompe disease. J. Pediatr. 148 (5), 671\u2013676 (2006).","journal-title":"J. Pediatr."},{"issue":"2","key":"78634_CR5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1542\/peds.112.2.332","volume":"112","author":"HM van den Hout","year":"2003","unstructured":"van den Hout, H. M. et al. The natural course of infantile pompe\u2019s disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 112 (2), 332\u2013340 (2003).","journal-title":"Pediatrics"},{"issue":"2","key":"78634_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","volume":"68","author":"PS Kishnani","year":"2007","unstructured":"Kishnani, P. S. et al. Recombinant human acid [alpha]-glucosidase: Major clinical benefits in infantile-onset pompe disease. Neurology. 68 (2), 99\u2013109 (2007).","journal-title":"Neurology"},{"issue":"15","key":"78634_CR7","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT van der Ploeg","year":"2010","unstructured":"van der Ploeg, A. T. et al. A randomized study of alglucosidase alfa in late-onset pompe\u2019s disease. N Engl. J. Med. 362 (15), 1396\u20131406 (2010).","journal-title":"N Engl. J. Med."},{"issue":"2","key":"78634_CR8","first-page":"132","volume":"3","author":"A Amalfitano","year":"2001","unstructured":"Amalfitano, A. et al. Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I\/II clinical trial. Genet. Med. 3 (2), 132\u2013138 (2001).","journal-title":"Genet. Med."},{"issue":"2","key":"78634_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1212\/01.wnl.0000252798.25690.76","volume":"68","author":"MA Kroos","year":"2007","unstructured":"Kroos, M. A. et al. Broad spectrum of pompe disease in patients with the same c.-32-13T->G haplotype. Neurology. 68 (2), 110\u2013115 (2007).","journal-title":"Neurology"},{"issue":"8","key":"78634_CR10","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1212\/WNL.55.8.1122","volume":"55","author":"P Laforet","year":"2000","unstructured":"Laforet, P. et al. Juvenile and adult-onset acid maltase deficiency in France: Genotype-phenotype correlation. Neurology. 55 (8), 1122\u20131128 (2000).","journal-title":"Neurology"},{"issue":"3","key":"78634_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ana.410380316","volume":"38","author":"JH Wokke","year":"1995","unstructured":"Wokke, J. H. et al. Genotype-phenotype correlation in adult-onset acid maltase deficiency. Ann. Neurol. 38 (3), 450\u2013454 (1995).","journal-title":"Ann. Neurol."},{"key":"78634_CR12","doi-asserted-by":"crossref","unstructured":"Kroos, M. A. et al. p.[G576S; E689K]: pathogenic combination or polymorphism in pompe disease? Eur. J. Hum. Genet. 16 (8), 875\u2013879 (2008).","DOI":"10.1038\/ejhg.2008.34"},{"issue":"4","key":"78634_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ymgme.2009.12.014","volume":"99","author":"P Labrousse","year":"2010","unstructured":"Labrousse, P. et al. Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program. Mol. Genet. Metab. 99 (4), 379\u2013383 (2010).","journal-title":"Mol. Genet. Metab."},{"issue":"11","key":"78634_CR14","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s10038-007-0191-9","volume":"52","author":"Y Tajima","year":"2007","unstructured":"Tajima, Y. et al. Structural and biochemical studies on Pompe disease and a pseudodeficiency of acid alpha-glucosidase. J. Hum. Genet. 52 (11), 898\u2013906 (2007).","journal-title":"J. Hum. Genet."},{"key":"78634_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40478-015-0243-x","volume":"3","author":"GJ Schaaf","year":"2015","unstructured":"Schaaf, G. J. et al. Lack of robust satellite cell activation and muscle regeneration during the progression of Pompe disease. Acta Neuropathol. Commun. 3, 65 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"78634_CR16","doi-asserted-by":"crossref","unstructured":"Kazi, Z. B. et al. Durable and sustained immune tolerance to ERT in Pompe disease with entrenched immune responses. JCI Insight ;1(11). (2016).","DOI":"10.1172\/jci.insight.86821"},{"issue":"11","key":"78634_CR17","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"78634_CR18","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51 (D1), D587\u2013D92 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"78634_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"78634_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS. 16 (5), 284\u2013287 (2012).","journal-title":"OMICS"},{"issue":"1","key":"78634_CR21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17 (1), 218 (2016).","journal-title":"Genome Biol."},{"issue":"5","key":"78634_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods. 12 (5), 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"issue":"1","key":"78634_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12883-017-0983-2","volume":"17","author":"B Schoser","year":"2017","unstructured":"Schoser, B. et al. The humanistic burden of pompe disease: Are there still unmet needs? A systematic review. BMC Neurol. 17 (1), 202 (2017).","journal-title":"BMC Neurol."},{"issue":"1","key":"78634_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12974-023-02965-w","volume":"20","author":"DA Gillett","year":"2023","unstructured":"Gillett, D. A., Wallings, R. L., Uriarte Huarte, O. & Tansey, M. G. Progranulin and GPNMB: Interactions in endo-lysosome function and inflammation in neurodegenerative disease. J. Neuroinflammation. 20 (1), 286 (2023).","journal-title":"J. Neuroinflammation"},{"key":"78634_CR25","doi-asserted-by":"publisher","first-page":"674739","DOI":"10.3389\/fimmu.2021.674739","volume":"12","author":"M Saade","year":"2021","unstructured":"Saade, M., Araujo de Souza, G., Scavone, C. & Kinoshita, P. F. The role of GPNMB in inflammation. Front. Immunol. 12, 674739 (2021).","journal-title":"Front. Immunol."},{"issue":"41","key":"78634_CR26","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1038\/s41388-022-02443-2","volume":"41","author":"AM Lazaratos","year":"2022","unstructured":"Lazaratos, A. M., Annis, M. G. & Siegel, P. M. GPNMB: A potent inducer of immunosuppression in cancer. Oncogene. 41 (41), 4573\u20134590 (2022).","journal-title":"Oncogene"},{"issue":"5","key":"78634_CR27","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.celrep.2019.01.030","volume":"26","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. The EF-Hand protein CALML6 suppresses antiviral innate immunity by impairing IRF3 dimerization. Cell. Rep. 26 (5), 1273\u201385e5 (2019).","journal-title":"Cell. Rep."},{"issue":"11","key":"78634_CR28","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.4049\/jimmunol.1901042","volume":"204","author":"C Sheng","year":"2020","unstructured":"Sheng, C. et al. CALML6 controls TAK1 ubiquitination and confers protection against acute inflammation. J. Immunol. 204 (11), 3008\u20133018 (2020).","journal-title":"J. Immunol."},{"issue":"2","key":"78634_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/15548627.2015.1009779","volume":"11","author":"JA Lim","year":"2015","unstructured":"Lim, J. A., Li, L., Kakhlon, O., Myerowitz, R. & Raben, N. Defects in calcium homeostasis and mitochondria can be reversed in pompe disease. Autophagy. 11 (2), 385\u2013402 (2015).","journal-title":"Autophagy"},{"issue":"4","key":"78634_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.tibs.2017.01.002","volume":"42","author":"S Hatakeyama","year":"2017","unstructured":"Hatakeyama, S. TRIM family proteins: roles in Autophagy, immunity, and Carcinogenesis. Trends Biochem. Sci. 42 (4), 297\u2013311 (2017).","journal-title":"Trends Biochem. Sci."},{"issue":"12","key":"78634_CR31","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/labinvest.3700484","volume":"86","author":"BL Thurberg","year":"2006","unstructured":"Thurberg, B. L. et al. Characterization of pre- and post-treatment pathology after enzyme replacement therapy for pompe disease. Lab. Invest. 86 (12), 1208\u20131220 (2006).","journal-title":"Lab. Invest."},{"issue":"13","key":"78634_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.21037\/atm.2019.05.27","volume":"7","author":"AK Desai","year":"2019","unstructured":"Desai, A. K., Li, C., Rosenberg, A. S. & Kishnani, P. S. Immunological challenges and approaches to immunomodulation in pompe disease: a literature review. Ann. Transl Med. 7 (13), 285 (2019).","journal-title":"Ann. Transl Med."},{"issue":"6","key":"78634_CR33","doi-asserted-by":"publisher","first-page":"e98336","DOI":"10.1371\/journal.pone.0098336","volume":"9","author":"S Nayak","year":"2014","unstructured":"Nayak, S. et al. Immune responses and hypercoagulation in ERT for Pompe disease are mutation and rhGAA dose dependent. PLoS One. 9 (6), e98336 (2014).","journal-title":"PLoS One"},{"key":"78634_CR34","doi-asserted-by":"publisher","first-page":"1336599","DOI":"10.3389\/fimmu.2024.1336599","volume":"15","author":"HA Chen","year":"2024","unstructured":"Chen, H. A. et al. Optimizing treatment outcomes: Immune tolerance induction in Pompe disease patients undergoing enzyme replacement therapy. Front. Immunol. 15, 1336599 (2024).","journal-title":"Front. Immunol."},{"issue":"6","key":"78634_CR35","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","volume":"155","author":"D Burzyn","year":"2013","unstructured":"Burzyn, D. et al. A special population of regulatory T cells potentiates muscle repair. Cell. 155 (6), 1282\u20131295 (2013).","journal-title":"Cell"},{"issue":"1","key":"78634_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13578-022-00847-x","volume":"12","author":"Z Chen","year":"2022","unstructured":"Chen, Z. et al. Regulatory T cells-centered regulatory networks of skeletal muscle inflammation and regeneration. Cell. Biosci. 12 (1), 112 (2022).","journal-title":"Cell. Biosci."},{"issue":"7993","key":"78634_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/d41586-023-03972-w","volume":"625","author":"G Coulis","year":"2024","unstructured":"Coulis, G. & Villalta, S. A. Muscle immune cells protect mitochondrial organelles during exercise. Nature. 625 (7993), 35\u201336 (2024).","journal-title":"Nature"},{"issue":"4","key":"78634_CR38","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s13311-018-0655-y","volume":"15","author":"L Kohler","year":"2018","unstructured":"Kohler, L., Puertollano, R. & Raben, N. Pompe disease: From basic science to therapy. Neurotherapeutics. 15 (4), 928\u2013942 (2018).","journal-title":"Neurotherapeutics"},{"key":"78634_CR39","doi-asserted-by":"publisher","first-page":"1381227","DOI":"10.3389\/fimmu.2024.1381227","volume":"15","author":"K Ma","year":"2024","unstructured":"Ma, K., Zhang, Y., Zhao, J., Zhou, L. & Li, M. Endoplasmic reticulum stress: Bridging inflammation and obesity-associated adipose tissue. Front. Immunol. 15, 1381227 (2024).","journal-title":"Front. Immunol."},{"issue":"8","key":"78634_CR40","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.4161\/auto.6.8.13378","volume":"6","author":"N Raben","year":"2010","unstructured":"Raben, N. et al. Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder\u2013murine pompe disease. Autophagy. 6 (8), 1078\u20131089 (2010).","journal-title":"Autophagy"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78634-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78634-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78634-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T07:11:38Z","timestamp":1731654698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78634-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78634"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78634-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27485"}}